61: HealthTech Hour with Steve Roest - Episode 61

61: HealthTech Hour with Steve Roest - Episode 61

In this engaging episode of HealthTech Hour, host Steve Roest introduces listeners to Giles Tully, the CEO of PinPoint Data Science—a company at the forefront of innovative cancer diagnostics. PinPoint's groundbreaking AI-driven blood test is designed to revolutionize how the NHS manages cancer referral pathways, offering a promising new tool in the fight against cancer. Giles Tully’s journey to becoming a health tech entrepreneur is as intriguing as the technology he now champions.

Before founding PinPoint Data Science, Giles was a pop star in China, a career that taught him valuable lessons about navigating unfamiliar cultures and complex bureaucracies—skills that have proven useful in dealing with the intricacies of the NHS. The episode delves into the challenges and opportunities presented by the PinPoint Test. Despite years of scientific research and thousands of potential biomarkers identified for cancer, substantial hurdles remain in integrating these findings into practical, life-saving applications.

Giles emphasizes the importance of collaboration with entities like Cancer Research UK and local medical councils to effectively deploy this technology within the healthcare system. Listeners are also treated to Giles’s personal philosophy on overcoming the hurdles of innovation. He shares wisdom gleaned from his diverse career experiences, highlighting the necessity of resilience and adaptability during tough times.

The discussion provides valuable insights not only into the technology itself but also into the mindset required to drive transformative change in the healthcare sector. Steve Roest’s own contributions to health tech through PocDoc are briefly mentioned, showcasing the diverse landscape of innovations emerging in the UK and beyond. This episode is a testament to the power of technology, collaboration, and perseverance in addressing some of the most pressing challenges in modern healthcare.